Call +44 (0)1904 798634 or +44 (0)7550 079918

Leading provider of life science market reports and research services

Genome Editing/Genome Engineering Market by Technology (CRISPR, TALEN, ZFN), Applications and End-User - Global Forecast to 2021

Be the first to review this product

Genome Editing/Genome Engineering Market by Technology (CRISPR, TALEN, ZFN), Applications (Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering), End User (Biotechnology & Pharmaceutical Companies, CROs) - Global Forecast to 2021
You can choose to pay by purchase order during checkout

Availability: In stock

$5,650.00

* Required Fields

You can choose to pay by purchase order during checkout
Markets and Markets

Digital downloads direct to your inbox within 24 hours.

First class customer service from our team of experts.

Pay by credit card or request an invoice

Product Description

Details

The genome editing market is projected to reach USD 5.54 billion by 2021 from USD 2.84 Billion in 2016, growing at a CAGR of 14.3% in the next five years (2016 to 2021). The growth of the overall market can be attributed to factors such as rising government funding and growth in the number of genomics projects, high prevalence rate of infectious diseases and cancer among patients, technological advancements, increasing demand for synthetic genes, growing awareness about genomics, and increasing new product launches by industry players are expected to drive the market in the coming years. Rise in the production of genetically modified crops is also expected to increase the demand for genome editing

The global market is segmented on the basis of technology, application, end user and region. On the basis of technology, the CRISPR segment is expected to command the largest share of the global market in 2016, it is also expected to grow at the highest CAGR from 2016 to 2021. The large market share and high growth rate of this technology segment can be attributed to the ease of use associated with the technology and reduction in off-target effect of CRISPR.

On the basis of applications, the cell line engineering segment is estimated to account for the largest share of the global market in 2016. This segment is also projected to have the highest growth rate in the forecast period. A number of factors such as increasing funding from governments and private organizations, growing industry focus on stem cell research, and increasing global awareness about stem cell therapies through various organizations are driving the growth of the cell line engineering applications segment

The biotechnology & pharmaceutical companies segment is estimated to account for the largest share of the global market in 2016 and it is also projected to have the highest growth rate in the forecast period. Owing to factors such as the rapidly increasing aging population and the growing prevalence of infectious diseases and cancer are propelling the demand for genome editing market for biotechnology & pharmaceutical companies.

In the coming years, the genome editing market is expected to witness the highest growth in the North America region. This regional segment is also expected to account for the largest share of the global market This can be attributed the development of gene therapy in the U.S.; increasing use of GM crops; prevalence of Alzheimer’s disease, dementia, infectious diseases, and cancer in the U.S.; growing availability of research grants and funding, and genome editing standards workshops and conferences.

The global market was dominated by the 3 major players including Thermo Fisher Scientific, Inc. (U.S.), Merck KGAA (Germany), and Horizon Discovery Group Plc (U.K.) in 2015. The other players of the market are Genscript Biotech Corporation (U.S.), Sangamo Biosciences, Inc. (U.S.), Integrated DNA Technologies, Inc (U.S.), Lonza Group Ltd. (Switzerland), New England Biolabs, Inc. (U.S.), Origene Technologies, Inc. (U.S.), and Transposagen Biopharmaceuticals, Inc. (U.S.).

Stakeholders of the Genome Editing Market 

  • Genome editing product manufacturers 
  • Genome editing product suppliers and distributors 
  • Medical research institutes 
  • Venture capitalists 
  • Community centers 
  • Regulatory bodies 

Scope of the Report:

This research report categorizes the global market into the following segments:

Genome Editing Market, by Technology

  • CRISPR 
  • TALEN 
  • ZFN 
  • Antisense 
  • Other Technologies 

Genome Editing Market, by Application

  • Cell Line Engineering 
  • Animal Genetic Engineering 
  • Plant Genetic Engineering 
  • Other Applications 

Genome Editing Market, by End User

  • Biotechnology & Pharmaceutical Companies 
  • Academic & Government Research Institutes 
  • Contract Research Organizations 
  • Other Applications 

Genome Editing Market, by Region

  • North America 
    • U.S. 
    • Canada 
  • Europe 
    • U.K. 
    • Germany 
    • Rest of Europe (RoE) 
  • Asia-Pacific 
    • China 
    • Japan 
    • India 
    • Rest of Asia-Pacific (RoAPAC) 
  • Rest of the World (RoW) 

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization option is available for the report:

Portfolio Assessment

Product Matrix, which gives a detailed comparison of the product portfolios of the top three companies in the market.

Additional Information

Additional Information

Publisher name Markets and Markets
Format PDF
Page count 180
Publication date 31 Oct 2016
Table of contents

Methodology and Table of Contents

Report Sample

Table of Contents

1 Introduction (Page No. - 17)
    1.1 Objectives of the Study 
    1.2 Market Definition 
    1.3 Market Scope 
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency 
    1.5 Limitations 
    1.6 Stakeholders 

2 Research Methodology (Page No. - 20)
    2.1 Research Methodology Steps 
    2.2 Secondary and Primary Research Methodology 
           2.2.1 Secondary Research
           2.2.2 Primary Research
                     2.2.2.1 Key Data From Primary Sources
                     2.2.2.2 Key Industry Insights
    2.3 Market Size Estimation Methodology 
           2.3.1 Market Data Validation and Triangulation
           2.3.2 Assumptions for the Study

3 Executive Summary (Page No. - 29)
    3.1 Introduction 
    3.2 Conclusion 

4 Premium Insights (Page No. - 34)
    4.1 Genome Editing: Market Overview 
    4.2 Geographic Analysis: Genome Editing Market, By Application (2016) 
    4.3 Market Size, By Technology, 2016 vs 2021 
    4.4 Market Size, By Application, 2016 vs 2021 
    4.5 Market Size, By End User, 2016 vs 2021 
    4.6 Geographical Snapshot of the Genome Editing Market 

5 Market Overview (Page No. - 38)
    5.1 Introduction 
    5.2 Market Dynamics 
           5.2.1 Drivers
                     5.2.1.1 Rising Government Funding and Growth in the Number of Genomics Projects
                     5.2.1.2 High Prevalence Rate of Infectious Diseases and Cancer Among Patients
                     5.2.1.3 Technological Advancements
                     5.2.1.4 Increase in Demand for Synthetic Genes
                     5.2.1.5 Rise in Production of Genetically Modified Crops
                     5.2.1.6 Increasing Awareness About Genomics
                     5.2.1.7 New Product Launches By Industry Players
           5.2.2 Restraints
                     5.2.2.1 High Cost of Genomic Equipment
                     5.2.2.2 Adverse Public Perception Related to Genetic Research
           5.2.3 Opportunities
                     5.2.3.1 Use of Genome Editing in Specialized/Personalized Medicine
                     5.2.3.2 Emerging Markets in Developing Countries
           5.2.4 Challenges
                     5.2.4.1 Off-Target Effect of CRISPR
                     5.2.4.2 Shortage of Trained Professionals

6 Global Genome Editing/Engineering Market, By Technology (Page No. - 48)
    6.1 Introduction 
    6.2 CRISPR 
    6.3 TALEN 
    6.4 ZFN 
    6.5 Antisense 
    6.6 Other Technologies 

7 Global Genome Editing/Genome Engineering Market, By Application (Page No. - 61)
    7.1 Introduction 
    7.2 Cell Line Engineering 
    7.3 Animal Genetic Engineering 
    7.4 Plant Genetic Engineering 
    7.5 Other Applications 

8 Global Genome Editing/Engineering Market, By End User (Page No. - 73)
    8.1 Introduction 
    8.2 Biotechnology & Pharmaceutical Companies 
    8.3 Academic & Government Research Institutes 
    8.4 Contract Research Organizations 

9 Genome Editing/Genome Engineering Market, By Region (Page No. - 81)
    9.1 Introduction 
    9.2 North America 
           9.2.1 U.S.
                     9.2.1.1 Development of Gene Therapy in the U.S.
                     9.2.1.2 Increasing Use of Gm Crops
                     9.2.1.3 Prevalence of Alzheimer’s Disease and Other Dementias in the United States
                     9.2.1.4 Genome Editing Conferences in the U.S.
                     9.2.1.5 Rising Availability of Research Grants and Funding
                     9.2.1.6 Genome Editing Standards Workshop in the U.S.
                     9.2.1.7 Increasing Prevalence of Cancer
                     9.2.1.8 Strategic Developments in the U.S. Market
           9.2.2 Canada
                     9.2.2.1 Availability of Research Funding in Canada
                     9.2.2.2 Rising Incidence of Cancer
                     9.2.2.3 Gapp to Intensify Genomic R&D
    9.3 Europe 
           9.3.1 Conferences and Meetings in Europe
           9.3.2 U.K.
                     9.3.2.1 Increased Funds, and Grants By Government Bodies
                     9.3.2.2 100,000 Genomes Project in U.K.
           9.3.3 Germany
                     9.3.3.1 Availability of Funding for Life Science Research
                     9.3.3.2 Conferences/Meetings/ Symposiums/Workshops in Germany
                     9.3.3.3 RoE
                     9.3.3.4 Spain’s Focus on Research
                     9.3.3.5 Growth in the Italian Biotech and Pharma Sectors
                     9.3.3.6 Growing Research Investments in Sweden & Denmark
    9.4 Asia-Pacific 
           9.4.1 China
                     9.4.1.1 High Intensity of R&D Activities in China
                     9.4.1.2 Growing Focus of Global Companies on China
           9.4.2 Japan
                     9.4.2.1 Involvement of Industry Players in the Japanese Market: Significant Developments
                     9.4.2.2 Conferences and Symposiums on Genetic Engineering in Japan
                     9.4.2.3 Focus on Cancer Research and Treatment
           9.4.3 India
                     9.4.3.1 Emergence of Local Players in India
                     9.4.3.2 Growth of the Pharmaceutical Industry in India
                     9.4.3.3 Development of Bio-Clusters to Boost India’s Biotechnology Industry
           9.4.4 RoAPAC
                     9.4.4.1 Australia: Availability of Financial Support for Research
                     9.4.4.2 Genome Asia 100k Initiative
                     9.4.4.3 Crop Research Initiatives in Asia
    9.5 RoW 
           9.5.1 Genetic Testing and Genomic Analysis in the Middle East
           9.5.2 Brazil: Investments in Research and Innovation Centers and Conferences & Workshops
           9.5.3 Rising Prevalence of Hiv, Cancer in Africa

10 Competitive Landscape (Page No. - 119)
     10.1 Overview 
     10.2 Market Share Analysis 
               10.2.1 Introduction
               10.2.2 Thermo Fisher Scientific, Inc.
               10.2.3 Merck KGaA
               10.2.4 Horizon Discovery Group PLC
     10.3 Competitive Situation and Trends 
               10.3.1 Agreements, Collaborations, and Partnerships
               10.3.2 Product & Service Launches
               10.3.3 Acquisitions
               10.3.4 Expansions
               10.3.5 Other Strategies
     10.4 Strategic Benchmarking 

11 Company Profiles (Page No. - 131)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
     11.1 Thermo Fisher Scientific, Inc. 
     11.2 Merck KGaA 
     11.3 Horizon Discovery Group PLC  
     11.4 Genscript USA Inc. 
     11.5 Sangamo Biosciences, Inc. 
     11.6 Integrated DNA Technologies, Inc. 
     11.7 Lonza Group Ltd. 
     11.8 New England Biolabs, Inc. 
     11.9 Origene Technologies, Inc. 
     11.10 Transposagen Biopharmaceuticals, Inc. 

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. - 152)
     12.1 Discussion Guide 
     12.2 Other Developments, By Company (2013–2016) 
     12.3 Knowledge Store: Marketsandmarkets’ Subscription Portal 
     12.4 Introducing RT: Real-Time Market Intelligence 
     12.5 Available Customizations 
     12.6 Related Reports 


List of Tables (105 Tables)

Table 1 Global Genome Editing Market Size, By Technology, 2014–2021 (USD Million)
Table 2 CRISPR-Based Genome Editing Market Size, By Region, 2014–2021 (USD Million)
Table 3 North America: CRISPR-Based Genome Editing Market Size, By Country, 2014–2021 (USD Million)
Table 4 Europe: CRISPR-Based Genome Editing Market Size, By Country, 2014–2021 (USD Million)
Table 5 Asia-Pacific: CRISPR-Based Genome Editing Market Size, By Country, 2014–2021 (USD Million)
Table 6 TALEN-Based Genome Editing Market Size, By Region, 2014–2021 (USD Million)
Table 7 North America: TALEN-Based Genome Editing Market Size, By Country, 2014–2021 (USD Million)
Table 8 Europe: TALEN-Based Genome Editing Market Size, By Country, 2014–2021 (USD Million)
Table 9 Asia-Pacific: TALEN-Based Genome Editing Market Size, By Country, 2014–2021 (USD Million)
Table 10 ZFN-Based Genome Editing Market Size, By Region, 2014–2021 (USD Million)
Table 11 North America: ZFN-Based Genome Editing Market Size, By Country, 2014–2021 (USD Million)
Table 12 Europe: ZFN-Based Genome Editing Market Size, By Country, 2014–2021 (USD Million)
Table 13 Asia-Pacific: ZFN-Based Genome Editing Market Size, By Country, 2014–2021 (USD Million)
Table 14 Antisense Technology-Based Genome Editing Market Size, By Region, 2014–2021 (USD Million)
Table 15 North America: Antisense Technology-Based Genome Editing Market Size, By Country, 2014–2021 (USD Million)
Table 16 Europe: Antisense Technology-Based Genome Editing Market Size, By Country, 2014–2021 (USD Million)
Table 17 Asia-Pacific: Antisense Technology-Based Genome Editing Market Size, By Country, 2014–2021 (USD Million)
Table 18 Other Genome Editing Technologies Market Size, By Region, 2014–2021 (USD Million)
Table 19 North America: Other Genome Editing Technologies Market Size, By Country, 2014–2021 (USD Million)
Table 20 Europe: Other Genome Editing Technologies Market Size, By Country, 2014–2021 (USD Million)
Table 21 Asia-Pacific: Other Genome Editing Technologies Market Size, By Country, 2014–2021 (USD Million)
Table 22 Global Genome Editing Market Size, By Application, 2014–2021 (USD Million)
Table 23 Market Size for Cell Line Engineering, By Region, 2014–2021 (USD Million)
Table 24 North America: Market Size for Cell Line Engineering, By Country, 2014–2021 (USD Million)
Table 25 Europe: Market Size for Cell Line Engineering, By Country/Region, 2014–2021 (USD Million)
Table 26 Asia-Pacific: Market Size for Cell Line Engineering, By Country/Region, 2014–2021 (USD Million)
Table 27 Market Size for Animal Genetic Engineering, By Region, 2014–2021 (USD Million)
Table 28 North America: Market Size for Animal Genetic Engineering, By Country, 2014–2021 (USD Million)
Table 29 Europe: Market Size for Animal Genetic Engineering, By Country/Region, 2014–2021 (USD Million)
Table 30 Asia-Pacific: Market Size for Animal Genetic Engineering, By Country/Region, 2014–2021 (USD Million)
Table 31 Market Size for Plant Genetic Engineering, By Region, 2014–2021 (USD Million)
Table 32 North America: Market Size for Plant Genetic Engineering, By Country, 2014–2021 (USD Million)
Table 33 Europe: Market Size for Plant Genetic Engineering, By Country/Region, 2014–2021 (USD Million)
Table 34 Asia-Pacific: Market Size for Plant Genetic Engineering, By Country/Region, 2014–2021 (USD Million)
Table 35 Market Size for Other Applications, By Region, 2014–2021 (USD Million)
Table 36 North America: Market Size for Other Applications, By Country, 2014–2021 (USD Million)
Table 37 Europe: Market Size for Other Applications, By Country/Region, 2014–2021 (USD Million)
Table 38 Asia-Pacific: Market Size for Other Applications, By Country/Region, 2014–2021 (USD Million)
Table 39 Global Market Size, By End User, 2014–2021 (USD Million)
Table 40 Market Size for Biotechnology and Pharmaceutical Companies, By Region, 2014–2021 (USD Million)
Table 41 North America: Market Size for Biotechnology and Pharmaceutical Companies, By Country, 2014–2021 (USD Million)
Table 42 Europe: Market Size for Biotechnology and Pharmaceutical Companies, By Country, 2014–2021 (USD Million)
Table 43 Asia-Pacific: Market Size for Biotechnology and Pharmaceutical Companies, By Country, 2014–2021 (USD Million)
Table 44 Market Size for Academic & Government Research Institutes, By Region, 2014–2021 (USD Million)
Table 45 North America: Market Size for Academic & Government Research Institutes, By Country, 2014–2021 (USD Million)
Table 46 Europe: Market Size for Academic & Government Research Institutes, By Region, 2014–2021 (USD Million)
Table 47 Asia-Pacific: Market Size for Academic & Government Research Institutes, By Country, 2014–2021 (USD Million)
Table 48 Market Size for Contract Research Organizations, By Region, 2014–2021 (USD Million)
Table 49 North America: Market Size for Contract Research Organizations, By Country, 2014–2021 (USD Million)
Table 50 Europe: Market Size for Contract Research Organizations, By Region, 2014–2021 (USD Million)
Table 51 Asia-Pacific: Market Size for Contract Research Organizations, By Country, 2014–2021 (USD Million)
Table 52 Market Size, By Region, 2014–2021 (USD Million)
Table 53 North America: Market Size, By Country, 2014–2021 (USD Million)
Table 54 North America: Market Size, By Technology, 2014–2021 (USD Million)
Table 55 North America: Market Size, By Application, 2014–2021 (USD Million)
Table 56 North America: Market Size, By End User, 2014–2021 (USD Million)
Table 57 U.S.: Market Size, By Technology, 2014–2021 (USD Million)
Table 58 U.S.: Market Size, By Application, 2014–2021 (USD Million)
Table 59 U.S.: Market Size, By End User, 2014–2021 (USD Million)
Table 60 Indicative List of Projects Funded By GAPP in 2014
Table 61 Canada: Market Size, By Technology, 2014–2021 (USD Million)
Table 62 Canada: Market Size, By Application, 2014–2021 (USD Million)
Table 63 Canada: Market Size, By End User, 2014–2021 (USD Million)
Table 64 Prominent Events in Europe
Table 65 Europe: Market Size, By Country, 2014–2021 (USD Million)
Table 66 Europe: Market Size, By Technology, 2014–2021 (USD Million)
Table 67 Europe: Market Size, By Application, 2014–2021 (USD Million)
Table 68 Europe: Market Size, By End User, 2014–2021 (USD Million)
Table 69 U.K.: Market Size, By Technology, 2014–2021 (USD Million)
Table 70 U.K.: Market Size, By Application, 2014–2021 (USD Million)
Table 71 U.K.: Market Size, By End User, 2014–2021 (USD Million)
Table 72 Events in Germany
Table 73 Germany: Market Size, By Technology, 2014–2021 (USD Million)
Table 74 Germany: Market Size, By Application, 2014–2021 (USD Million)
Table 75 Germany: Market Size, By End User, 2014–2021 (USD Million)
Table 76 RoE: Market Size, By Technology, 2014–2021 (USD Million)
Table 77 RoE: Market Size, By Application, 2014–2021 (USD Million)
Table 78 RoE: Market Size, By End User, 2014–2021 (USD Million)
Table 79 Asia-Pacific: Market Size, By Country, 2014–2021 (USD Million)
Table 80 Asia-Pacific: Market Size, By Technology, 2014–2021 (USD Million)
Table 81 Asia-Pacific: Market Size, By Application, 2014–2021 (USD Million)
Table 82 Asia-Pacific: Market Size, By End User, 2014–2021 (USD Million)
Table 83 China: Market Size, By Technology, 2014–2021 (USD Million)
Table 84 China: Market Size, By Application, 2014–2021 (USD Million)
Table 85 China: Market Size, By End User, 2014–2021 (USD Million)
Table 86 Conferences, Symposia, & Workshops in Japan (2016)
Table 87 Japan: Genome Editing Market Size, By Technology, 2014–2021 (USD Million)
Table 88 Japan: Genome Editing Market Size, By Application, 2014–2021 (USD Million)
Table 89 Japan: Genome Editing Market Size, By End User, 2014–2021 (USD Million)
Table 90 India: Genome Editing Market Size, By Technology, 2014–2021 (USD Million)
Table 91 India: Genome Editing Market Size, By Application, 2014–2021 (USD Million)
Table 92 India: Genome Editing Market Size, By End User, 2014–2021 (USD Million)
Table 93 RoAPAC: Genome Editing Market Size, By Technology, 2014–2021 (USD Million)
Table 94 RoAPAC: Genome Editing Market Size, By Application, 2014–2021 (USD Million)
Table 95 RoAPAC: Genome Editing Market Size, By End User, 2014–2021 (USD Million)
Table 96 Hiv Infections and Aids-Related Deaths in the Middle East and Africa, 2014
Table 97 RoW: Genome Editing Market Size, By Technology, 2014–2021 (USD Million)
Table 98 RoW: Genome Editing Market Size, By Application, 2014–2021 (USD Million)
Table 99 RoW: Genome Editing Market Size, By End User, 2014–2021 (USD Million)
Table 100 Agreements, Collaborations, and Partnerships (2013–2016)
Table 101 Product & Service Launches (2013–2016)
Table 102 Acquisitions (2013–2016)
Table 103 Expansions (2013–2016)
Table 104 Other Strategies (2013–2016)
Table 105 Market Developments Between 2013 & 2016
 
 
List of Figures (45 Figures)
 
Figure 1 Global Genome Editing Market Segmentation
Figure 2 Global Genome Editing Market: Research Methodology
Figure 3 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 4 Bottom-Up Approach
Figure 5 Top-Down Approach
Figure 6 Research Design
Figure 7 Data Triangulation Methodology
Figure 8 Global Genome Editing Market Analysis, By Technology (2016-2021)
Figure 9 Global Genome Editing Market Analysis, By Application, 2016 vs 2021
Figure 10 Global Genome Editing Market Analysis, By End User, 2016 vs 2021
Figure 11 Global Genome Editing Market, By Region, 2016 – 2021
Figure 12 Genome Editing Market Projected to Witness A Double-Digit Growth Rate in the Forecast Period
Figure 13 Cell Line Engineering Segment to Dominate the Genome Editing Market in 2016
Figure 14 CRISPR Segment to Witness the Highest Growth Rate During Forecast Period
Figure 15 Cell Line Engineering Segment to Grow at the Highest CAGR During the Forecast Period
Figure 16 Biotechnology & Pharmaceutical Companies to Command the Largest Market Share in 2016
Figure 17 North America to Witness the Highest Growth Rate During the Forecast Period
Figure 18 Drivers, Restraints, Opportunities, Challenges, and Trends
Figure 19 Global Genome Editing Market, By Technology, 2016 vs 2021
Figure 20 North America is Estimated to Account for the Largest Share of CRISPR-Based Genome Editing Market
Figure 21 Global Genome Editing Market Size, By Application, 2016 vs 2021
Figure 22 North America is Estimated to Account for the Largest Share of the Cell Line Engineering Market
Figure 23 Genome Editing Market, By End User (2016 vs 2021)
Figure 24 Genome Editing Market, By Region, 2016 vs 2021
Figure 25 North America: Genome Editing Market Snapshot
Figure 26 Prevalence of Alzheimer's Disease in U.S., 2015.
Figure 27 Europe: Genome Editing Market Snapshot
Figure 28 Asia-Pacific: Genome Editing Market Snapshot
Figure 29 RoW: Genome Editing Market Snapshot
Figure 30 Agreements, Partnerships and Collaborations are the Major Strategies Adopted By the Key Players, 2013–2016
Figure 31 Market Share Analysis, By Key Player (2015)
Figure 32 Agreements, Collaborations, and Partnerships Key Growth Strategy Adopted By Market Players
Figure 33 Agreements, Collaborations, and Partnerships, By Company (2013–2016)
Figure 34 Product & Service Launches, By Company (2013–2016)
Figure 35 Acquisitions, By Company (2013–2016)
Figure 36 Expansions, By Company (2013–2016)
Figure 37 Other Strategies, By Company (2013–2016)
Figure 38 Geographic Revenue Mix of Market Players
Figure 39 Thermo Fisher Scientific, Inc.: Company Snapshot
Figure 40 Merck KGaA: Company Snapshot
Figure 41 Sigma-Aldrich Corporation: Company Snapshot
Figure 42 Horizon Discovery Group PLC: Company Snapshot
Figure 43 Genscript USA Inc.: Company Snapshot
Figure 44 Sangamo Biosciences, Inc.: Company Snapshot
Figure 45 Lonza Group Ltd.: Company Snapshot

Reviews

Write Your Own Review

Only registered users can write reviews. Please, log in or register

Product Tags

Product Tags

Use spaces to separate tags. Use single quotes (') for phrases.